Literature DB >> 18133471

The use of N-ethyl-o-crotonotoluidide in the treatment of scabies and various pruritic dermatoses.

M COUPERUS.   

Abstract

Entities:  

Keywords:  PRURITUS/therapy; SCABIES/therapy

Mesh：

Substances：

Year:  1949        PMID： 18133471     DOI： 10.1038/jid.1949.63

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

1.  Topical anaesthetics in skin disorders; a survey of the literature.

Authors:  W R BETT
Journal:  Postgrad Med J       Date:  1956-04       Impact factor: 2.401

2.  Transient receptor potential vanilloid 4 (TRPV4) channel as a target of crotamiton and its bimodal effects.

Authors:  Hiroki Kittaka; Yu Yamanoi; Makoto Tominaga
Journal:  Pflugers Arch       Date:  2017-06-13       Impact factor: 3.657

3.  Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989-90.

Authors:  Masae Tsutsumi; Hiroshi Nishiura; Toshio Kobayashi
Journal:  BMC Infect Dis       Date:  2005-10-14       Impact factor: 3.090

4.  Crotamiton, an Anti-Scabies Agent, Suppresses Histamine- and Chloroquine-Induced Itch Pathways in Sensory Neurons and Alleviates Scratching in Mice.

Authors:  Da-Som Choi; Yeounjung Ji; Yongwoo Jang; Wook-Joo Lee; Won-Sik Shim
Journal:  Biomol Ther (Seoul)       Date:  2020-11-01       Impact factor: 4.634
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.